Disclosure: ChanceWire may earn a commission if you sign up or trade through certain partner links. SoftCta only until partner tokens allow hard CTAs. Read How we make money and our Affiliate disclosure. Not financial advice. Informational only — not legal, tax, or investment advice. Digital assets and event contracts involve substantial risk of loss.

Relative vs absolute risk in study and trial headlines

Health and science headlines often report that a treatment "cuts risk by half" or that a factor "doubles the risk." Those statements are usually relative. Without the absolute numbers, they can be misleading. Event contracts on clinical trial readouts, drug approvals or health statistics depend on reading these numbers precisely. This SoftCta guide explains the main measures.

Relative versus absolute

Absolute risk is the probability of an event in a group: 2 in 100 people, for example. Relative risk compares two groups. If a treatment lowers risk from 2% to 1%, the relative risk reduction is 50%, but the absolute reduction is one percentage point. Both are accurate, but they create very different impressions. Our guide on percent versus percentage point covers the same distinction in economic data.

Number needed to treat

Number needed to treat converts an absolute risk difference into a more intuitive figure: how many people need a treatment for one to benefit. It is one divided by the absolute risk reduction. A one-point reduction gives 100; a ten-point reduction gives 10. Our guide on natural frequencies explains why counts like these are easier to reason about than percentages.

Efficacy figures

Vaccine efficacy is a relative measure: it compares the rate of disease in vaccinated and unvaccinated groups within a trial. A 90% efficacy figure means the vaccinated group had 90% fewer cases relative to the control group, under the trial conditions. It does not mean 10% of vaccinated people get sick.

Hazard ratios and endpoints

Trials of long-term outcomes often report hazard ratios, which compare event rates over time. A hazard ratio of 0.75 suggests a 25% lower event rate, assuming the ratio is roughly constant. Trials also have prespecified primary endpoints and significance thresholds, usually reported with a p-value and confidence interval. A contract on whether a trial "meets its primary endpoint" settles on the company's or researchers' reported result for that endpoint, which our clinical trial readout guide explains.

Headlines versus contract terms

Press releases tend to lead with relative figures and favourable secondary endpoints. A contract may ask something narrower: did the primary endpoint reach statistical significance, did the hazard ratio fall below a level, or did a regulator approve. Our FDA approval guide covers how regulators weigh benefit against risk, often using absolute numbers.

Base rates matter

The same relative change means different things depending on the starting risk. Doubling a one-in-a-million risk is still tiny; doubling a one-in-ten risk is large. Our guide on base rates explains why starting points matter.

A reading habit

• Look for the absolute numbers in both groups.
• Calculate the absolute difference and number needed to treat.
• Identify the primary endpoint and how the contract defines success.
• Read the full release, not just the headline percentage.

Convert prices with the implied probability tool and verify live prices on the venue.

Primary sources SoftCta readers open

• Clinical trial registries (ClinicalTrials.gov) and primary endpoints
• Peer-reviewed publications and supplementary tables
• Company topline press releases and SEC filings
• Regulatory briefing documents

Reading the quote step by step

• Read the full title and rules, including the named settlement source and the time zone.
• Convert the Yes and No prices to implied probabilities and note the gap between them.
• Subtract fees and spread to see the effective price you would actually face.
• Write your own probability range and the evidence behind it, then compare.
• Check related and near-duplicate markets on other venues for consistency.

Closing SoftCta checklist

• Re-read the venue definition in your own words before reacting to a price.
• Convert prices with fee and spread awareness; verify live cents on the operator.
• Prefer primary settlement sources over secondary headlines and social summaries.
• Treat ChanceWire hubs, movers, and tools as orientation — not order entry.
• Confirm age, location, and product eligibility; SoftCta pages will not suggest location spoofing.
• If clarity is incomplete, watching is a complete SoftCta outcome — no pick-selling urgency required.

SoftCta habits

• Write your own probability range before checking the crowd price.
• Prefer dated primary sources over social summaries.
• Compare related markets when a single book looks extreme.
• Size curiosity with fees and depth in mind; substantial risk of loss.